Biosims Technologies Overview
- Founded
-
2010
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Liquidation
Biosims Technologies General Information
Description
Developer and manufacturer of high-performance analytical tools for life science industries. The company's Dynaxi detection platform, its software and kits allows extremely low amounts of targets in a sample to be monitored, at a level never reached so far on a chip device.
Contact Information
Website
www.biosims-technologies.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Primary Office
- Seine biopolis II
- 75, Route de Lyons la forêt
- 76000 Rouen
- France
+33 09 00 00 00 00
Biosims Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Bankruptcy: Liquidation | 27-Dec-2016 | 00.000 | Completed | Bankruptcy: Liquidation | ||
| 4. Early Stage VC | 22-May-2015 | 00.000 | 00.000 | Completed | Startup | |
| 3. Early Stage VC | 12-Dec-2013 | Completed | Startup | |||
| 2. Debt - General | Completed | Startup | ||||
| 1. Grant | Completed | Startup |
Biosims Technologies Patents
Biosims Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3023792-A1 | Spot control | Withdrawn | 18-Nov-2014 | 00000000000 | 0 |
| EP-2478372-A1 | Improved method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) | Granted | 15-Sep-2009 | 00000000000 | |
| US-20120172249-A1 | Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) | Abandoned | 15-Sep-2009 | 00000000000 | |
| CA-2774125-A1 | Improved method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) | Abandoned | 15-Sep-2009 | 00000000000 | |
| EP-2478372-B1 | Improved method and array for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) | Not-In-Force | 15-Sep-2009 | G01N33/6848 |
Biosims Technologies Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Christine Heuclin | Chief Executive Officer & Co-Founder | ||
| Jean Belouard | Sales Manager & European Sales Director | ||
| Guillaume Legent Ph.D | Co-Founder & Senior Scientist |
Biosims Technologies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
